interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Drug shortage outlook › Dexamethasone Sodium Phosphate

Shortage outlook · all drugs · read October 2026

How long has Dexamethasone Sodium Phosphate been on the FDA shortage list?

Dexamethasone Sodium Phosphate has been on the FDA shortage list for 7 years and 6 months. 20 of the 397 listings measured since 2014 lasted at least that long. Only 20 past listings reached this age, too few to show a share. The counts are below. These are counts of listings, not a forecast.

Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). FDA list read October 2026.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.
Dexamethasone Sodium Phosphateon the FDA shortage list now
90months listed

Dexamethasone Sodium Phosphate has been on the FDA shortage list for 7 years and 6 months (May 2019 to October 2026).

  1. 20 of the 397 listings measured since 2014 lasted at least that long.
  2. Only 20 past listings reached this age, too few to show a share. The counts are below.
  3. Dexamethasone Sodium Phosphate has been listed 2 times since 2014: earlier listings lasted 2 years and 11 months.
  4. None of this predicts an end date. A listing ends when the FDA removes it, which reflects supply across the whole country, and says nothing about one pharmacy's shelf.

The listing history, to scale

  1. Dexamethasone Sodium Phosphate InjectionListed June 2014 to April 2017 · 2 years and 11 months · already listed when the archive began
  2. Dexamethasone Sodium Phosphate InjectionListed since May 2019 · 7 years and 6 months

What past listings of this age did

Of past listings that had already run 7 years and 6 months, how many were still listed later?

After 6 more monthstoo few listings to show a share17 listings measured
After 12 more monthstoo few listings to show a share16 listings measured
After 24 more monthstoo few listings to show a share4 listings measured

What the FDA list says about it today

19presentations listed
5companies
8 February 2019first posted

Reasons companies gave: demand increase for the drug (5); 14 of 19 gave none. FDA category: Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Other; Pulmonary/Allergy; Rheumatology.

Company by company

Of 19 presentations, the companies reported 15 available, 0 with limited availability and 4 unavailable. This is each company's own report to the FDA, with the date of its last update.

FDA shortage list read October 2026 (monthly archived copies since 2014, rebuilt in the published dataset; current listing file read 11 November 2026). Listing is the FDA's status, not a statement about any pharmacy.

Where can you go from this result?

This result is one of 61 drugs on the list now. Open it in the lookup to search another drug, or read how the listings were measured.

To check what is available now, ask your pharmacist, and see FDA drug shortage information and the FDA drug shortages database.